¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Anaphylactic shock due to serum"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® shock ÇÑ±Û ¼îÅ©, Ãæ°Ý
¼³¸í   
  1. Á¤½ÅÀû ÆòÇüÀÇ µ¹¿¬ÇÑ Àå¾Ö. 2. ¾î¶°ÇÑ ¿øÀÎÀ¸·Î ÁøÇ༺ÀΠ¸»ÃʼøÈ¯ºÎÁ·ÀÇ °á°ú·Î Á¶Á÷ÀÇ »ê¼ÒºÎÁ·ÁõÀ» ÀÏÀ¸ÄѠź»ê°¡½º³ª À¯»êµîÀÇ ´ë»ç»ê¹°ÀÇ ÃàÀûÀ» ÀÏÀ¸Å² »óŸ¦ ¸»ÇÑ´Ù. ¼îÅ©ÀÇ ÀÓ»óÁõ»óÀº ¨ç ÇǺÎÀǠâ¹é, ¨è ¼Õ¹ßÅé¸ð¼¼Ç÷°üÀÇ ÀçÃæ¸¸ Áö¿¬, ¨é ÀǽÄÀå¾Ö, ¨ê Ç÷¾ÐÇϰ­, ¸Æ¹Ú±äÀåÀúÇÏ, ¨ë ¿ä·®°¨¼Ò µîÀÌ´Ù. ¼îÅ©ÀÇ ºÐ·ù¿¡´Â 1Â÷¼º¼îÅ©, 2Â÷¼º¼îÅ©°¡ ÀÖÀ¸¸ç ¼øÈ¯µ¿Å¿¡ ÀÇÇÑ ºÐ·ù·Î¼­ ÀúÇ÷·ù·®¼º¼îÅ©, ¸»ÃÊÇ÷°üÈ®À强¼îÅ©, ½ÉÀ强¼îÅ©°¡ ÀÖ´Ù. º´ÀÎÀûÀΠºÐ·ù·Î¼­ ½Å°æÅ¿¼îÅ©, ¾Æ³ªÇǶô½Ã½º¼îÅ©, ±¹¼Ò¸¶Ãë¾à Áßµ¶ÀÇ °á°ú·Î ÀϾ´Â ¼îÅ© µîÀÌ ÀÖ´Ù.
¿µ¹® serum ÇÑ±Û Ç÷û
¼³¸í   
  Ç÷¾×ÀÇ ¼ººÐ Áß °íÇü¼ººÐÀΠÇ÷±¸¼¼Æ÷(ÀûÇ÷±¸, ¹éÇ÷±¸ µî), Ç÷¼ÒÆÇÀ» Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ÀåÀ̶ó°í Çϰí, Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¸¦ Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ûÀ̶ó°í ÇÑ´Ù.
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
¿µ¹® serum enzyme ÇÑ±Û Ç÷ûȿ¼Ò
¼³¸í   
  Ç÷û ³»¿¡ Æ÷ÇԵǾî Àִ ¿©·¯ °¡Áö È¿¼Ò¸¦ ÀÏÄ´ ¸»ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©
  • serum shock
    Ç÷û¼îÅ©
  • anaphylactic antibody
    ¾Æ³ªÇʶô½Ã½ºÇ×ü
  • anaphylactic gangrene
    ¾Æ³ªÇʶô½Ã½º±«Àú
  • anaphylactic intoxication
    ¾Æ³ªÇʶô½Ã½º¼ºÁßµ¶, Ãʰú¹Î¹ÝÀÀ¼îÅ©
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • antilymphocytic serum
    Ç׸²ÇÁ±¸Ç÷û
  • antiplatelet serum
    Ç×Ç÷¼ÒÆÇÇ÷û
  • antirabies serum
    Ç×±¤°ßº´Ç÷û
  • antitetanic serum
    ÇׯĻódzÇ÷û
  • antithymocyte serum
    Ç×°¡½¿»ù¼¼Æ÷Ç÷û, Ç×Èä¼±¼¼Æ÷Ç÷û
  • antitoxic serum
    Ç×µ¶¼ÒÇ÷û
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • allergenic serum
    ¾Ë·¹¸£±âÇ÷û
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • serum hepatitis
    Ç÷û°£¿°
  • serum
    Ç÷û
  • serum sickness
    Ç÷ûº´
  • serum typing
    Ç÷ûÇü°Ë»ç
  • extracorporeal shock wave lithotripsy
    ¸ö¹ÛÃæ°ÝÆÄµ¹±þ¼ú, ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú
  • shock
    ¼îÅ©, Ãæ°Ý
  • hypovolemic shock
    Ç÷¾×·®°¨¼ÒÁõ
  • neurogenic shock
    ½Å°æ¼º¼îÅ©, ½Å°æÅ¿¼îÅ©
  • shock treatment
    Ãæ°ÝÄ¡·á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼îÅ©, Ãʰú¹Î¹ÝÀÀ¼îÅ©
  • serum shock
    Ç÷û¼îÅ©
  • anaphylactic gangrene
    ¾Æ³ªÇʶô½Ã½º±«Àú
  • anaphylactic intoxication
    (¢¡anaphylactic shock) ¾Æ³ªÇʶô½Ã½º¼îÅ©, Ãʰú¹Î¹ÝÀÀ¼îÅ©
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • anaphylactic antibody
    ¾Æ³ªÇʶô½Ã½ºÇ×ü
  • acute phase serum
    ±Þ¼º±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×Ç÷ûºñ
  • allergenic serum
    ¾Ë·¹¸£°Õ¼ºÇ÷û
  • antilymphocytic serum
    Ç׸²ÇÁ±¸Ç÷û
  • antiplatelet serum
    Ç×Ç÷¼ÒÆÇÇ÷û
  • antirabies serum
    Ç×¹ÌÄ£°³º´Ç÷û
  • antitetanic serum
    ÇׯĻódzÇ÷û
  • antithymocyte serum
    Ç×°¡½¿»ù¼¼Æ÷Ç÷û
  • antitoxic serum
    Ç×µ¶¼ÒÇ÷û
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¼º ¹ÝÀÀ(¡­Úãëë).
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã¼º ¹ÝÀÀ(¡­Úãëë).
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀ(Úãëë),Ãʰú¹Î¹ÝÀÀ
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • Heat shock protein
    ¿­¼ï´Ü¹éÁú
  • Hypovolemic shock
    Ç÷¾×·®°¨¼Ò(úìäûÕáÊõá´)¼îÅ©
  • Insulin shock
    Àν¶¸°¼ï
  • Irreversible shock
    ºñ°¡¿ªÀû(ުʦæ½îÜ) ¼ï
  • gram negative shock
    ±×·¥À½¼º¼ï.
  • heat shock
    ¿­Ãæ°Ý
  • heat shock protein
    ¿­Ãæ°Ý´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹éÁú
  • heat shock protein
    ¿­Ãæ°Ý ´Ü¹é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • jaundice due to biliary stasis
    ´ãÁó¿ïü¼º Ȳ´Þ(ÓÅñðê¦ôòàõüÜÓ¸).
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã¼º ¼ï, °ú¹Î¼º ¼ï.
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º¼º ¼ï, °ú¹Î¼º ¼ï.
  • serum shock
    Ç÷û¼ï.
  • serum shock
    Ç÷û¼ï(úìôè¡­)
  • anaphylactic antibody
    ¾Æ³ªÇʶô½Ã¼º Ç×ü(¡­ù÷ô÷).
  • anaphylactic antibody
    ¾Æ³ªÇʶô½Ã½º [À¯¹ß]Ç×ü
  • anaphylactic gangrene
    ¾Æ³ªÇʶô½Ã¼º ±«Àú(¡­ÎÕîÅ).
  • anaphylactic gangrene
    ¾Æ³ªÇʶô½Ã½º¼º ±«Àú(¡­ÎÕîÅ).
  • anaphylactic intoxication
    ¾Æ³ªÇʶô½Ã¼º Áßµ¶(¡­ñéÔ¸).
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã¼º ¹ÝÀÀ(¡­Úãëë).
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀ(Úãëë),Ãʰú¹Î¹ÝÀÀ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¼º ¹ÝÀÀ(¡­Úãëë).
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic shock
    ¾Æ³ªÇʶô½Ã½º ¼îÅ©
  • anaphylactic response
    ¾Æ³ªÇʶô½Ã½º ´ëÀÀ(Óßëë)
  • cold shock
    ³Ã(Ò²) ¼ïÅ©
  • heat shock protein
    ¿­(æð)
  • heat shock puff
    ¿­(æð)
  • heat shock response
    ¿­(æð)
  • insulin shock
    Àν¶¸° ¼ï
  • irreversible shock
    ºñ°¡¿ª(ުʦæ½)¼ï
  • osmotic shock
    »ïÅõ(ß¶÷â)
  • shock-sensitive permease
  • acute serum
    ±Þä Ç÷û(Ðáóõúìôè)
  • antilymphocyte serum
    Ç×Àӯı¸Ç÷û(ù÷×ú÷éϹúìôè)
  • blood serum
    Ç÷û(úìôè)
  • immune serum
    ¸é¿ª Ç÷û(Øóæ¹úìôè)
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypoglycemic shock
    ÀúÇ÷´ç¼º¼ï, Àν¶¸°¼ï
  • septic shock
    ÆÐÇ÷¼º¼ï
  • shock wave
    Ãæ°ÝÆÄ
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®¼ú
  • radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÈ­Ç÷û¾ËºÎ¹Î
  • serum
    Ç÷û
  • serum amylase
    Ç÷û¾Æ¹Ð¶ó¾ÆÁ¦
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ
  • serum protein
    Ç÷û´Ü¹é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LCAR late cutaneous anaphylactic reaction
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
HSP Health Systems Plan; heat shock protein; hemostatic screening profile; Henoch-Schonlein purpura; her...
d/t due to
dt due to; dystonic
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AS anaphylactic shock
DUE DNA unwinding element
DUE Drug usage evaluation
PCA Passive cutaneous anaphylactic
HSP 2)/heat shock protein
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • T80.5
    Anaphylactic shock due to serum
    Ç÷û¿¡ ÀÇÇÑ ¾Æ³ªÇʶô½Ã½º¼º ¼îÅ©
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • jaundice due to biliary stasis
    ´ãÁó ¿ïü¼º Ȳ´Þ
  • anaphylactic
    ¾Æ³ªÇʶô½Ã¼º, °ú¹ÎÀÇ
    ¾Æ³ªÇʶô½Ã½º¿¡ °üÇÑ.
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã¼º ¹ÝÀÀ
  • circulatory shock
    ¼øÈ¯¼º ¼ï
  • convulsive shock therapy
    °æ·Ã ¼ï ¿ä¹ý
  • diastolic shock
    È®Àå±â ¼ï
  • drug shock
    ¾à¹° Ãæ°Ý
  • dye shock
    »ö¼Ò Ãæ°Ý
  • hyperglycemic shock
    °íÇ÷´ç¼º ¼ï
  • neurogenic shock
    ½Å°æ¼º ¼ï, ½Å°æ¿ø¼º ¼ï
  • oligemic shock
    ÇÌÇ÷¼º ¼ï
  • operation shock
    ¼ö¼ú ¼ï
  • pain shock
    µ¿Åë ¼ï
  • physiologic shock absorber
    »ý¸®Àû Ãæ°Ý Èí¼ö´ë
  • post electric shock syndrome
    Àü°Ý ¼ï ÈÄ ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anaphylactic shock <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
serum shock Anaphylactic or anaphylactoid shock caused by the injection of antitoxic or other foreign serum.
(05 Mar 2000)
due date The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC).
(12 Dec 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
thrombotic disease due to protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
anaphylactic <immunology> Pertaining to anaphylaxis.
(18 Nov 1997)
anaphylactic antibody Antibody that has an affinity for certain kinds of cells, in addition to and unrelated to its specific affinity for the antigen that induced it, because of the properties of the Fc portion of the heavy chain.
See: heterocytotropic antibody, homocytotropic antibody, cytotropic antibody test.
Synonym: anaphylactic antibody, cytophilic antibody.
(05 Mar 2000)
anaphylactic intoxication Intoxication following an anaphylactic reaction.
(05 Mar 2000)
anaphylactic reaction <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaesthetic shock Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage.
(05 Mar 2000)
anaphylactoid shock A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions.
Synonym: anaphylactoid crisis, pseudoanaphylactic shock.
(05 Mar 2000)
break shock The shock produced by breaking a constant current passing through the body.
(05 Mar 2000)
cardiac shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
cardiogenic shock A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy.
Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic
    ¼º¿åÀ» ¾ïÁ¦ÇÏ´Â;¼º¿å ¾ïÁ¦Á¦
  • serum
    Ç÷û
  • immune serum
    ¸é¿ª Ç÷û
  • serum
    Àå¾×;Ç÷û
  • truth serum
    Áø½É Åä·Î¾à (¸ÔÀ¸¸é Áø½ÉÀ» Åоî³õ´Â´Ù´Â ¾à)
  • due
    Á¤´çÇÑ,-¿¡ ÀÇÇÑ,Á¤È®È÷
  • due
    ÀÀ´çÄ¡·¯¾ßÇÒ;ÀÀ´ç;¿¡ µ¹¿©¾ßÇÒ;ÇÒ ¿¹Á¤ÀÎ;´ç¿¬ÇÒ;Á¤½ÄÀ¸·Î;¶§°¡ ¿À¸é;¸¶¶¥È÷;¼¼±Ý
  • due bill
    Â÷¿ë Áõ¼­
  • due date
    ¾îÀ½ÀÇ ¸¸±âÀÏ
  • due process
    (¹ý)Á¤´çÇÑ ¹ýÀÇ ÀýÂ÷(¹Ì±¹ Çå¹ý Á¦ 5Á¶,Á¦ 14Á¶)
  • postage due
    ¿ìÆí ¿ä±Ý ºÎÁ·
  • shock
    Ãæ°Ý,Ãæ°ÝÀ» ÁÖ´Ù,³î¶ó´Ù
  • corn shock
    ¿Á¼ö¼ö ³ëÀû°¡¸®
  • culture shock
    ¹®È­ ¼îÅ©(ÀÌÁúÀûÀÎ ¹®È­³ª »õ·Î¿î »ýȰ ¾ç½ÄÀ» Á¢ÇÒ ¶§ ¹Þ´Â Ãæ°Ý)
  • earthquake shock
    ÁöÁø(ÀÇ Áøµ¿)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á